Atlas Trials

Nalrexone Facilitated Discontinuation of Buprenorphine

Clinical trial NCT01895036 · COMPLETED

Trial details

NCT number
NCT01895036
Sponsor
New York State Psychiatric Institute
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Stable Opioid Dependence
Start date
2011-02-01
Primary completion
2013-09-01
Enrollment
6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.